New pill aims to slow lung scarring in IPF patients
Disease control
Recruiting now
This study tests an experimental pill called PIPE-791 in people with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs and makes breathing hard. About 324 adults aged 40 and older will receive either the drug or a placebo to see if it helps preserve lung functio…
Phase: PHASE2 • Sponsor: Contineum Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC